StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted by Year

FDA 510(k) Medical Device/Diagnostic Clearances Granted to Thermo Fisher (openFDA)

Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted: 15 in FY2025, up 36.4% from a year earlier.

Latest, FY2025
15
Period ended Dec 31, 2025
Change on a year earlier
+36.4%
11 in FY2024
History
10 years
Since FY2016
Sources
1
openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries

Where the FY2025 figure comes from

Source: openFDA 510(k) Premarket Notifications — Thermo Fisher & Subsidiaries ↗

Monthly, quarterly, and annual data series (2016–Q3 2026) aggregated directly from the openFDA database for all TMO subsidiaries (Thermo Fisher, Life Technologies, Phadia, Oxoid, Remel, One Lambda, Brammer, Affymetrix...).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up FDA 510 Medical Device/Diagnostic Clearances Granted

Cite this data

StockData. (2026). Thermo Fisher Scientific FDA 510 Medical Device/Diagnostic Clearances Granted, annual FY2016–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-510k-company

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.